首页> 外文期刊>Clinical Chemistry: Journal of the American Association for Clinical Chemists >Effect of Acute Coronary Syndrome Probability on Diagnostic and Prognostic Performance of High-Sensitivity Cardiac Troponin
【24h】

Effect of Acute Coronary Syndrome Probability on Diagnostic and Prognostic Performance of High-Sensitivity Cardiac Troponin

机译:急性冠状动脉综合征概率对高敏感性心肌肌钙蛋白诊断和预后性能的影响

获取原文
           

摘要

BACKGROUND: There is concern that high-sensitivity cardiac troponin (hs-cTn) may have low diagnostic accuracy in patients with low acute coronary syndrome (ACS) probability. METHODS: We prospectively stratified patients presenting with acute chest discomfort to the emergency department (ED) into 3 groups according to their probability for ACS as assessed by the treating ED physician using a visual analog scale: a?¤10%, 11% to 79%, and a?¥80%, reviewing all information available at 90 min. hs-cTnT and hs-cTnI concentrations were determined in a blinded fashion. Two independent cardiologists adjudicated the final diagnosis. RESULTS: Among 3828 patients eligible for analysis, 1189 patients had low (a?¤10%) probability for ACS. The incidence of non-ST-segment elevation myocardial infarction (NSTEMI) increased from 1.3% to 12.2% and 54.8% in patients with low, intermediate, and high ACS probability, respectively. The positive predictive value of hs-cTnT and hs-cTnI was low in patients with low ACS probability and increased with the incidence of NSTEMI, whereas the diagnostic accuracy of hs-cTnT and hs-cTnI for NSTEMI as quantified by the area under the curve (AUC) was very high and comparable among all 3 strata, e.g., AUC hs-cTnI, 0.96 (95% CI, 0.94a??0.97); 0.87 (95% CI, 0.85a??0.89); and 0.89 (95% CI, 0.87a??0.92), respectively. Findings were validated using bootstrap analysis as an alternative methodology to define ACS probability. Similarly, higher hs-cTnT/I concentrations independently predicted all-cause mortality within 2 years (e.g., hs-cTnT hazard ratio, 1.39; 95% CI, 1.27a??1.52), irrespective of ACS probability. CONCLUSIONS: Diagnostic and prognostic accuracy and utility of hs-cTnT and hs-cTnI remain high in patients with acute chest discomfort and low ACS probability. ClinicalTrials.gov Identifier: [NCT00470587][1]. [1]: /lookup/external-ref?link_type=CLINTRIALGOV&access_num=NCT00470587&atom=%2Fclinchem%2F64%2F3%2F515.atom
机译:背景:担心高灵敏度心肌肌蛋白(HS-CTN)可能对低急性冠状动脉综合征(ACS)概率的患者具有低诊断准确性。方法:我们预期分层患者将急性胸部不适与急诊部(ED)呈现为3组,根据ACS使用视觉模拟规模评估的ACS评估:a?¤10%,11%至79 %,A 80%,审查90分钟的所有信息。 HS-CTNT和HS-CTNI浓度以致盲的方式确定。两个独立的心脏病学家裁决最终诊断。结果:3828名符合分析患者中,1189名患者对ACS的概率低(a?¤10%)。非ST段升高心肌梗死(NSTemi)的发病率分别从低,中间和高ACS概率的患者增加了1.3%至12.2%和54.8%。低ACS概率患者HS-CTNT和HS-CTNI的阳性预测值较低,随着NSTEMI的发生率而增加,而NSTEMI的HS-CTNT和HS-CTNI的诊断准确性被曲线下的区域量化为量化(AUC)在所有3层间非常高,相当,例如AUC HS-CTNI,0.96(95%CI,0.94A〜0.97); 0.87(95%CI,0.85A 0.89);分别为0.89(95%CI,0.87A〜0.92)。使用引导分析作为替代方法进行验证的调查结果以定义ACS概率。类似地,较高的HS-CTNT / I浓度在2年内独立地预测了所有原因死亡率(例如,HS-CTNT危险比,1.39; 95%CI,1.27A?1.52),无论ACS概率如何。结论:急性胸部不适和低ACS概率的患者HS-CTNT和HS-CTNI的诊断和预后准确性和效用仍然很高。 ClinicalTrials.gov标识符:[NCT00470587] [1]。 [1]:/lookup/external-ref ?link_type=clintrialg &access_num=nct00470587&atom=%2fclinchem%2f64%2f3%2f515.atom

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号